← back to search

Magdalena Cerdá

Hospital Luis Calvo Mackenna · CL
Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes, HIV, Drug Use, Sexual Risk, and Cannabis and Cannabinoid Research.
h-index
73
citations
17,923
works
427
NIH funding
primary concept
email

Recent publications

Completeness and quality of comprehensive managed care data compared with fee‐for‐service data in national Medicaid claims from 2001 to 2019
Health Services Research 2025cited by 14position: middledoi
Changes in Synthetic Opioid–Involved Youth Overdose Deaths in the United States: 2018–2022
PEDIATRICS 2025cited by 11position: middledoi
Integrating Artificial Intelligence into Causal Research in Epidemiology
Current Epidemiology Reports 2025cited by 9position: middledoi
A state-level history of opioid overdose deaths in the United States: 1999-2021
PLoS ONE 2024cited by 17position: lastdoi
Social and economic determinants of drug overdose deaths: a systematic review of spatial relationships
Social Psychiatry and Psychiatric Epidemiology 2024cited by 13position: middledoi
Pain Management Treatments and Opioid Use Disorder Risk in Medicaid Patients
American Journal of Preventive Medicine 2024cited by 11position: middledoi
Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022
JAMA Network Open 2024cited by 10position: middledoi
Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties
Epidemiology 2024cited by 8position: firstdoi
State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019
JAMA Psychiatry 2023cited by 47position: middledoi
Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.”
The American Journal of Drug and Alcohol Abuse 2023cited by 40position: middledoi
Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019
Pain 2023cited by 31position: middledoi
Typology of laws restricting access to methadone treatment in the United States: A latent class analysis
International Journal of Drug Policy 2023cited by 30position: lastdoi
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states
International Journal of Drug Policy 2023cited by 27position: middledoi
Outcome class imbalance and rare events: An underappreciated complication for overdose risk prediction modeling
Addiction 2023cited by 26position: middledoi
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington
International Journal of Drug Policy 2023cited by 26position: lastdoi
One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and Washington
JAMA Psychiatry 2023cited by 21position: middledoi
Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study
The Lancet Psychiatry 2023cited by 18position: middledoi
Understanding the differential effect of local socio‐economic conditions on the relation between prescription opioid supply and drug overdose deaths in US counties
Addiction 2023cited by 18position: middledoi
Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study
The Lancet Regional Health - Americas 2023cited by 16position: middledoi
Changes in Opioid and Benzodiazepine Poisoning Deaths After Cannabis Legalization in the US: A County-level Analysis, 2002–2020
Epidemiology 2023cited by 15position: lastdoi
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”
International Journal of Drug Policy 2022cited by 302position: lastdoi
What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
Drug and Alcohol Dependence Reports 2022cited by 219position: lastdoi
Forecasted and Observed Drug Overdose Deaths in the US During the COVID-19 Pandemic in 2020
JAMA Network Open 2022cited by 59position: middledoi
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19
Addiction 2022cited by 50position: middledoi
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018
Journal of Pain 2022cited by 38position: middledoi
Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records
Drug and Alcohol Dependence 2022cited by 38position: middledoi
When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws
Epidemiology 2022cited by 32position: lastdoi
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay
Addiction 2022cited by 22position: lastdoi
Scaling Interventions to Manage Chronic Disease: Innovative Methods at the Intersection of Health Policy Research and Implementation Science
Prevention Science 2022cited by 22position: middledoi
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Journal of Substance Abuse Treatment 2021cited by 139position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Katherine M. Keyes · Columbia University35 papers (2013–2024)Sílvia S. Martins · Columbia University Irving Medical Center24 papers (2015–2025)Deborah S. Hasin · Columbia University Irving Medical Center23 papers (2016–2025)David S. Fink · Columbia University19 papers (2018–2024)Ariadne Rivera‐Aguirre · New York University15 papers (2018–2024)Álvaro Castillo‐Carniglia · New York University14 papers (2018–2023)Brandon D. L. Marshall · Brown University13 papers (2018–2023)Melanie M. Wall · New York University12 papers (2016–2024)Corey S. Davis · National Health Law Program10 papers (2018–2023)William R. Ponicki · University of California, Berkeley9 papers (2016–2023)Noa Krawczyk · New York University9 papers (2020–2025)Salomeh Keyhani · San Francisco VA Medical Center8 papers (2018–2024) · 8 papers (2016–2023)Kara E. Rudolph · Columbia University8 papers (2019–2024)Scott E. Hadland · Harvard University6 papers (2018–2021)Danielle C. Ompad · New York University6 papers (2013–2020)Andrew J. Saxon · Seattle University6 papers (2022–2024)Charles Maynard · University of Colorado Denver6 papers (2022–2024)Aaron L. Sarvet · Columbia University6 papers (2016–2020)Zachary L. Mannes · Columbia University5 papers (2022–2024)